6Karlowsky JA, Thomsberry C, Jones ME,et al. Factors associated with relative rates of antimierobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998--2002). Clin Infect Dis, 2003,36: 963-970.
7Adam HJ, Schurek KN, Nichol KA, et al. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005. Antimicrob Agents Chemother,2007,51 : 198-207.
8中华人民共和国卫生部办公厅.关于进一步加强抗菌药物临床应用管理的通知.2008-04-15.
9Tiemei Z, Xiangqun F, Youning L. Resistence phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shengyang, China. Antimicrob Agents Chemother,2004, 48 : 4040-4041.
10Yamazaki T, Sasaki T, Takahata M. Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoiae. Antimicrob Agents Chemother, 2007, 51: 2278- 2279.
